Foundation review: Current therapies in ischemic stroke. Part A. Recent developments in acute stroke treatment and in stroke prevention

被引:46
作者
Broussalis, Erasmia [1 ]
Killer, Monika [1 ]
McCoy, Mark [2 ,3 ]
Harrer, Andrea [1 ]
Trinka, Eugen [1 ]
Kraus, Joerg [1 ]
机构
[1] Paracelus Med Univ, Christian Doppler Klin, Dept Neurol, A-5020 Salzburg, Austria
[2] Paracelus Med Univ, Christian Doppler Klin, Dept Radiol, A-5020 Salzburg, Austria
[3] MRT, A-5020 Salzburg, Austria
关键词
FACTOR XA INHIBITOR; CEREBRAL-ARTERY OCCLUSION; SECONDARY PREVENTION; ATRIAL-FIBRILLATION; DOUBLE-BLIND; POOLED ANALYSIS; INTRAVENOUS THROMBOLYSIS; VENOUS THROMBOEMBOLISM; MYOCARDIAL-INFARCTION; RECURRENT STROKE;
D O I
10.1016/j.drudis.2011.11.005
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Stroke is the third leading cause of death with an increasing prevalence. In previous years many important achievements and new therapeutic strategies have been established. This article provides an overview on recent developments and is an update to the article of Green et al that was published in 2004. As this article is a comprehensive review we divided it in two parts. In this Part A of our review, recent developments in acute stroke treatment and in stroke prevention are described. In Part B we will reflect on neuroprotection.
引用
收藏
页码:296 / 309
页数:14
相关论文
共 123 条
[1]
(2010) The Executive Steering Committee on behalf of the ROCKET AF Study Investigators, 2010, AM HEART J, V159, P247
[2]
Entity of inhibition of platelet aggregation and clinical events: new evidence obtained with prasugrel [J].
Abbate, Rosanna ;
Crea, Filippo ;
De Servi, Stefano ;
Filippi, Erica ;
Gensini, Gian Franco ;
Golino, Paolo ;
Savonitto, Stefano .
GIORNALE ITALIANO DI CARDIOLOGIA, 2010, 11 (02) :127-137
[3]
Emergency administration of abciximab for treatment of patients with acute ischemic stroke:: Results of an international phase III trial -: Abciximab in emergency treatment of stroke trial (AbESTT-II) [J].
Adams, Harold P., Jr. ;
Effron, Mark B. ;
Torner, James ;
Davalos, Antoni ;
Frayne, Judith ;
Teal, Philip ;
Leclerc, Jacques ;
Oemar, Barry ;
Padgett, Lakshmi ;
Barnathan, Elliot S. ;
Hacke, Werner .
STROKE, 2008, 39 (01) :87-99
[4]
CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[5]
Adams HP, 2000, STROKE, V31, P601
[6]
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack [J].
Adams, Robert J. ;
Albers, Greg ;
Alberts, Mark J. ;
Benavente, Oscar ;
Furie, Karen ;
Goldstein, Larry B. ;
Gorelick, Philip ;
Halperin, Jonathan ;
Harbaugh, Robert ;
Johnston, S. Claiborne ;
Katzan, Irene ;
Kelly-Hayes, Margaret ;
Kenton, Edgar J. ;
Marks, Michael ;
Sacco, Ralph L. ;
Schwamm, Lee H. .
STROKE, 2008, 39 (05) :1647-1652
[7]
A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement [J].
Agnelli, G. ;
Haas, S. ;
Ginsberg, J. S. ;
Krueger, K. A. ;
Dmitrienko, A. ;
Brandt, J. T. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (04) :746-753
[8]
Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR [J].
Ahmed, Niaz ;
Wahlgren, Nils ;
Grond, Martin ;
Hennerici, Michael ;
Lees, Kennedy R. ;
Mikulik, Robert ;
Parsons, Mark ;
Roine, Risto O. ;
Toni, Danilo ;
Ringleb, Peter .
LANCET NEUROLOGY, 2010, 9 (09) :866-874
[9]
Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial [J].
Alexander, John H. ;
Becker, Richard C. ;
Bhatt, Deepak L. ;
Cools, Frank ;
Crea, Filippo ;
Dellborg, Mikael ;
Fox, Keith A. A. ;
Goodman, Shaun G. ;
Harrington, Robert A. ;
Huber, Kurt ;
Husted, Steen ;
Lewis, Basil S. ;
Lopez-Sendon, Jose ;
Mohan, Puneet ;
Montalescot, Gilles ;
Ruda, Mikhail ;
Ruzyllo, Witold ;
Verheugt, Freek ;
Wallentin, Lars ;
Darius, Harald ;
Simoons, Maarten ;
Boersma, Eric ;
DeLemos, James ;
Spencer, Fred .
CIRCULATION, 2009, 119 (22) :2877-U39
[10]
CLOTBUST: Design of a randomized trial of ultrasound-enhanced thrombolysis for acute ischemic stroke [J].
Alexandrov, AV ;
Wojner, AW ;
Grotta, JC .
JOURNAL OF NEUROIMAGING, 2004, 14 (02) :108-112